Arena Pharmaceuticals

Traded on the St. Petersburg Stock Exchange
Arena Pharmaceuticals is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company’s most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), etrasimod (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn’s disease.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Arena Pharmaceuticals balance sheet

Report period2016 2017 2018 2019 2020 2021
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Arena Pharmaceuticals cash flows

Report period2016 2017 2018 2019 2020 2021
End date of the reporting period
Sales
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Arena Pharmaceuticals multipliers

Report period2016 2017 2018 2019 2020 2021
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Arena Pharmaceuticals profitability

Report period2016 2017 2018 2019 2020 2021
ROA
ROE
ROS
EBITDA Margin
Operating margin
Arena Pharmaceuticals assets
Arena Pharmaceuticals cash flows
Arena Pharmaceuticals news
11.03.2022
Pfizer completed its acquisition of Arena Pharmaceuticals for $6.7 billion, or $100 a share.
24.02.2022
Arena Pharmaceuticals' GAAP loss for 2021 was $616.433 million, up 52.3% from $404.734 million in the previous year. Revenue decreased 5.9 times to $54,000 from $319,000 a year earlier.
13.12.2021
Pfizer acquires Arena Pharmaceuticals for $6.7 billion, or $100 per share. The deal is scheduled to close in the first half of 2022.
05.11.2021
Arena Pharmaceuticals reported a GAAP loss of $460.824 million for 9M2021, up 63.1% from $282.573 million in the previous year. The company had no revenues. A year earlier the figure was $282 thousand.
General information
Company nameArena Pharmaceuticals
Tags#pharmacy
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
Mailing address6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Websitewww.arenapharm.com
Information disclosurewww.sec.gov